MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.

Li, Maolan

MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. [electronic resource] - Oncotarget Dec 2016 - 83060-83070 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.13067 doi


Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Cell Survival--drug effects
Cisplatin--pharmacology
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm--genetics
Gallbladder Neoplasms--drug therapy
Gene Expression Profiling--methods
Gene Expression Regulation, Neoplastic
Humans
Male
Mice, Nude
MicroRNAs--genetics
Neoplasm Invasiveness
Oligonucleotide Array Sequence Analysis
Proto-Oncogene Mas
Proto-Oncogene Proteins c-akt--metabolism
Proto-Oncogene Proteins c-bcl-2--metabolism
RNA Interference
Signal Transduction--drug effects
Time Factors
Transfection
Tumor Burden--drug effects
Xenograft Model Antitumor Assays
bcl-2-Associated X Protein--metabolism
src-Family Kinases--genetics